Manu Jaggi

Title: Manu Jaggi: Innovator in Cancer Treatment

Introduction

Manu Jaggi is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. With a total of 2 patents, his work focuses on innovative methods and compositions that aim to improve cancer treatment outcomes.

Latest Patents

One of Manu Jaggi's latest patents is a pharmaceutical composition designed for the treatment of cancer. This composition is useful for killing or inhibiting the multiplication of cancer cells. It is expected to prevent, inhibit, or modulate the hypersecretion of various peptides, including VIP, somatostatin, bombesin, and Substance P. The composition may consist of a therapeutically effective combination of peptide analogs of these substances. Additionally, he has developed a method of treatment for humans or animals suffering from cancer, which involves administering a therapeutically effective dose of the pharmaceutical composition to inhibit cancer cell multiplication. This method is particularly beneficial for treating cancers of the colon and rectum.

Another significant patent involves a novel method for establishing tumor-cell lines from biopsies of human or animal tumors. This method includes preparing a single-cell suspension of tumor cells by injecting cell culture medium into an isolated tumor. The process involves piercing the tumor with a needle to flush out the tumor cells, which are then cultured to establish a primary tumor cell culture.

Career Highlights

Manu Jaggi is affiliated with the National Institute of Immunology, where he conducts his research and development work. His innovative approaches in cancer treatment have garnered attention in the scientific community.

Collaborations

Manu Jaggi collaborates with fellow researcher Rama Mukherjee, contributing to advancements in cancer research and treatment methodologies.

Conclusion

Manu Jaggi's contributions to cancer treatment through his innovative patents and research at the National Institute of Immunology highlight his commitment to improving healthcare outcomes. His work continues to pave the way for new therapeutic approaches in the fight against cancer.